‘Tomudex’ (raltitrexed) plus oxaliplatin (Eloxatin) in previously untreated metastatic colorectal cancer (MCRC) patients: an active combination

Autor:	Jaafar Bennouna, S. Nasca, J H Jacob, Thierry Conroy, Jean-Luc Raoul, F.Bertheault Cvitkovic, Bernard Paillot, Yves Becouarn, M. Ychou, Erick Gamelin, M. Smith, A. Fandi, Eric Francois, Jean-Yves Douillard, J.F. Seitz
Rok vydání:	1999
Předmět:	Oncology Cancer Research medicine.medical_specialty Colorectal cancer business.industry Internal medicine medicine medicine.disease business Raltitrexed medicine.drug Oxaliplatin
Zdroj:	European Journal of Cancer. 35:S75
ISSN:	0959-8049
DOI:	10.1016/s0959-8049(99)80670-4
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4eb110187a221e3687e98da4aabe3cf0 https://doi.org/10.1016/s0959-8049(99)80670-4 Zobrazit plný text záznamu Full Text from ScienceDirect